Characterization of the main placental cytokine profiles from HIV-1-infected pregnant women treated with anti-retroviral drugs in France.
about
Association between maternal HIV infection and low birth weight and prematurity: a meta-analysis of cohort studiesTransfer of Maternal Antimicrobial Immunity to HIV-Exposed Uninfected NewbornsSeverity of maternal HIV-1 disease is associated with adverse birth outcomes in Malawian women: a cohort study.Plasmodium falciparum infection significantly impairs placental cytokine profile in HIV infected Cameroonian women.Impact of maternal HIV-1 viremia on lymphocyte subsets among HIV-exposed uninfected infants: protective mechanism or immunodeficiency.The impact of maternal HIV infection on cord blood lymphocyte subsets and cytokine profile in exposed non-infected newborns.Low birth weight in perinatally HIV-exposed uninfected infants: observations in urban settings in Cameroon.Impaired humoral response to vaccines among HIV-exposed uninfected infantsInsights Into Circulating Cytokine Dynamics During Pregnancy in HIV-Infected Beninese Exposed to Plasmodium falciparum Malaria.Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2 years of life.Trypanosoma cruzi (Chagas' disease agent) reduces HIV-1 replication in human placenta.Effect of multivitamin supplementation on measles vaccine response among HIV-exposed uninfected Tanzanian infantsHigher Transplacental Pathogen-Specific Antibody Transfer Among Pregnant Women Randomized to Triple Antiretroviral Treatment Versus Short Course Zidovudine.Immunogenicity of Hepatitis B Vaccine in HIV Exposed Uninfected Infants.Do children exposed to human immunodeficiency virus but not infected actually have a more robust response to hepatitis B vaccination than their nonexposed peers?Altered Toll-Like Receptor-4 Response to Lipopolysaccharides in Infants Exposed to HIV-1 and Its Preventive Therapy.
P2860
Q26785714-71D9CF15-D029-4308-86E3-DD7520EC90BEQ28070259-E6674E80-8492-4B7D-982D-5DA052847664Q30222338-3AC93D69-7065-4F60-B7A2-CFF9CDF52ED4Q30940547-64BE00F0-1EA4-467C-A018-3E0B5F4EF4EAQ33624111-6F884E3C-B322-42AC-A4E5-9E9140B3CD7CQ33811277-F80B7366-DDC2-4EC0-A23E-9488175C5A92Q35140240-5A9AFF70-1D9A-4B56-861E-8CE71BB5E7EEQ35191100-E8ED505F-4C47-42F4-8691-CB488E5A8F12Q35933924-FBA2EFCA-1773-48A1-94BA-8A0168981FDFQ36504806-C1353C06-500C-440A-80AA-6711B8B372A7Q36766584-A4BEC396-CF0D-42B7-8FE1-00DAC9F9C927Q37124693-AD9B23DE-EF9E-4BB0-8DBD-7C9D72671F6BQ40073325-C2D9858E-9467-4DED-8DA9-24F5E97A207EQ40959540-436956CA-2A0B-4C2A-AC3F-4C4047A3A7FAQ43071613-8ADE2E82-29DB-4A58-AF91-750F2921ED7CQ52680555-4A44C42F-0DC3-42F6-A92E-5BDE280884CD
P2860
Characterization of the main placental cytokine profiles from HIV-1-infected pregnant women treated with anti-retroviral drugs in France.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Characterization of the main p ...... ti-retroviral drugs in France.
@en
Characterization of the main p ...... ti-retroviral drugs in France.
@nl
type
label
Characterization of the main p ...... ti-retroviral drugs in France.
@en
Characterization of the main p ...... ti-retroviral drugs in France.
@nl
prefLabel
Characterization of the main p ...... ti-retroviral drugs in France.
@en
Characterization of the main p ...... ti-retroviral drugs in France.
@nl
P2093
P2860
P1476
Characterization of the main p ...... ti-retroviral drugs in France.
@en
P2093
ANRS 1267 study team and the HIV-1 PMTCT-PlaNet
S Pornprasert
P2860
P304
P356
10.1111/J.1365-2249.2007.03411.X
P577
2007-05-18T00:00:00Z